The manufacturer's parent firm recently told investors it's grappling with $100 million in anticipated costs from tariffs.

The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

Australian agencies and companies have earned four graphite pencils at the D&AD Awards overnight. Melbourne Based design ...

Generation Mining Limited ("Gen Mining" or the "Company") is pleased to announce receipt of a support letter from a leading Canadian financial institution stating its interest to provide up to $200 ...

Spending on cancer drugs is expected to reach $441B globally in 2029 despite a slowdown later in the decade as key oncology medicines lose market exclusivity, drug analytics and contract research firm ...

Bristol Myers Squibb is storming ASCO 2025 with data from over 80 studies covering 20+ cancer types, showcasing its oncology ...

A few days after the film’s premiere, I had lunch with Squibb in her hotel room, and we talked about the movie, her ...

For those attending Saturday’s 15th annual Men’s Rally in the Valley, ” a 300-pound wooden cross will be on display inside Stambaugh Auditorium in Youngstown. It was carried ...

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to pause dosing in another ...

The European Commission has approved Eisai and Biogen's Leqembi for a subset of patients with early-stage Alzheimer's disease, setting it up to become the first amyloid-targeting drug to reach the ...

How to find your results and what they mean for your next stage of study. View your assessment results View your assessment and reassessment (resit) marks, and unit results. What your results mean ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.